Vincent A. Pollack

Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice

Vincent A. Pollack, Douglas M. Savage, Deborah A. Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 430 citations

CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Kam Fai Tse, Michael Jeffers, Vincent A. Pollack et al. · Clinical Cancer Research · 2006 · 186 citations

Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB

Vincent A. Pollack, Enrique Álvarez, Kam Fai Tse et al. · Cancer Chemotherapy and Pharmacology · 2007 · 82 citations

Antibody–drug Conjugate, Tumor Biology, Drug Targeting +12

Direct activation of tumoricidal properties in rat alveolar macrophages by Nocardia rubra cell wall skeleton

Saburo Sone, Vincent A. Pollack, Isaiah J. Fidler · Cancer Immunology Immunotherapy · 1980 · 31 citations

Inflammation, Tumoricidal Properties, Medicine +10

N-(5-fluorobenzothiazol-2-yl)-2-guanidinothiazole-4-carboxamide. A novel, systemically active antitumor agent effective against 3LL Lewis Lung carcinoma

Rodney C. Schnur, Anton Fliri, Shama Kajiji et al. · Journal of Medicinal Chemistry · 1991 · 20 citations